SEC Form 4 · accession 0001144204-17-003608
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey W. Runge
Director
Period of report
Jan 20, 2017
Accepted (ET)
Jan 24, 2017 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Jan 20, 2017 | M | 20,000 | $3.11 | A | 197,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.11 | Jan 20, 2017 | M | 20,000 | D | Jun 23, 2012 | Jun 23, 2021 | Common Stock | 20,000 | 0 | D |